Quantum Biopharma amends Form 6-K to add exhibit to F-3 registration statement
QNTM•Amended filing updates earlier report
Quantum Biopharma filed an amended Form 6-K to update its earlier March 30, 2026 report.
The amendment incorporated a previously issued March 30, 2026 press release into its Form F-3 registration statement.
No other changes were made to the initial filing, beyond the incorporation-by-reference update.
